Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionCENTRAL TRUST Co
Latest Disclosed Ownership112 shares
Latest Disclosed Value $ 22,361
CENTRAL TRUST Co ownership in LGND / Ligand Pharmaceuticals Incorporated

On April 17, 2026 - CENTRAL TRUST Co filed a 13F-HR form disclosing ownership of 112 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $22,361 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 112 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $26,253 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 112 0 0.00 22 4.76 0.0002
2026-02-02 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 112 8 7.69 21 16.67 0.0004
2025-11-06 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 104 -62 -37.35 18 0.00 0.0004
2025-08-07 2025-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 166 0 0.00 19 5.88 0.0004
2025-04-18 2025-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 166 0 0.00 17 0.00 0.0004
2025-01-24 2024-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 166 131 374.29 18 466.67 0.0004
2024-10-22 2024-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 4 50.00 0.0001
2024-08-05 2024-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 3 0.00 0.0001
2024-04-24 2024-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 3 0.00 0.0001
2024-01-24 2023-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 2 0.00 0.0001
2023-10-26 2023-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 2 0.00 0.0001
2023-07-26 2023-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 3 0.00 0.0001
2023-04-19 2023-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 3 0.00 0.0001
2023-01-26 2022-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 2 -33.33 0.0001
2022-11-17 2022-09-30 13F/A-2 LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 3 0.00 0.0001
2022-11-04 2022-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 3 0.0001
2022-11-03 2022-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 3 0.0001
2022-08-09 2022-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35 0 0.00 3 -25.00 0.0001
2022-05-03 2022-03-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 0 0.00 4 -20.00 0.0001
2022-02-08 2021-12-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 0 0.00 5 0.00 0.0001
2021-10-19 2021-09-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 0 0.00 5 0.00 0.0002
2021-07-23 2021-06-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 0 0.00 5 0.00 0.0002
2021-04-23 2021-03-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 0 0.00 5 66.67 0.0002
2021-01-29 2020-12-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 -50 -58.82 3 -62.50 0.0001
2020-10-22 2020-09-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 85 -23 -21.30 8 -33.33 0.0004
2020-07-14 2020-06-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 108 0 0.00 12 50.00 0.0006
2020-04-17 2020-03-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 108 30 38.46 8 0.00 0.0005
2020-01-21 2019-12-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 78 -7 -8.24 8 0.00 0.0004
2019-10-28 2019-09-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 85 -21 -19.81 8 -33.33 0.0005
2019-07-12 2019-06-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 106 0 0.00 12 -7.69 0.0007
2019-04-26 2019-03-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 106 7 7.07 13 0.00 0.0008
2019-01-08 2018-12-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 99 0 0.00 13 -51.85 0.0009
2018-10-04 2018-09-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 99 -28 -22.05 27 3.85 0.0016
2018-07-09 2018-06-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 127 10 8.55 26 36.84 0.0017
2018-04-04 2018-03-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 117 -94 -44.55 19 -34.48 0.0012
2018-01-23 2017-12-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 211 0 0.00 29 0.00 0.0018
2017-10-17 2017-09-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 211 0 0.00 29 11.54 0.0019
2017-07-14 2017-06-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 211 -242 -53.42 26 -45.83 0.0017
2017-04-06 2017-03-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 453 8 1.80 48 6.67 0.0032
2017-01-24 2016-12-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 445 -59 -11.71 45 -11.76 0.0031
2016-10-24 2016-09-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 504 3 0.60 51 -15.00 0.0037
2016-08-08 2016-06-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 501 -4 -0.79 60 11.11 0.0045
2016-04-11 2016-03-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 505 40 8.60 54 8.00 0.0043
2016-01-21 2015-12-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 465 191 69.71 50 117.39 0.0041
2015-10-14 2015-09-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 274 -34 -11.04 23 -25.81 0.0020
2015-07-28 2015-06-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 308 31 11.19 31 47.62 0.0024
2015-04-09 2015-03-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 277 0 0.00 21 40.00 0.0017
2015-01-16 2014-12-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 277 -18 -6.10 15 7.14 0.0012
2014-10-23 2014-09-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 295 260 742.86 14 600.00 0.0011
2014-05-07 2014-03-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 0 0.00 2 0.00 0.0002
2014-01-27 2013-12-31 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 0 0.00 2 0.00 0.0002
2013-10-24 2013-09-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 0 0.00 2 100.00 0.0002
2013-08-13 2013-06-30 13F LIGAND PHARMACEUTICALS COMMON STOCK 53220K504 35 35 1 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.